GO:0140253 cell-cell fusion: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140253 cell-cell fusion is a biological process in which two or more cells combine by plasma membrane fusion, producing a single cell; nuclei may fuse to form a polyploid cell or remain separate to form a syncytium.
• Cell-cell fusion is essential in development and homeostasis, including fertilization, myoblast fusion, osteoclast formation, placental syncytiotrophoblast formation, and macrophage fusion into multinucleated giant cells.
• Phosphatidylserine exposure and lipid signaling are conserved triggers of cell-cell fusion, acting through fusogenic proteins such as syncytins and other fusogens.
• Pathological cell-cell fusion contributes to cancer progression, metastasis, and therapy resistance, and is considered a potential emerging cancer hallmark.
• Viruses, including betaherpesviruses and other enveloped viruses, exploit cell-cell fusion to form syncytia and spread infection.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of fusogens and fusion-regulatory pathways in development and disease.
Description
Cell-cell fusion (GO:0140253) is a fundamental biological process in which two or more cells merge through plasma membrane fusion to form a single cell. Depending on the context, the nuclei of the fused cells may also fuse, producing a polyploid cell, or they may remain separate, producing a syncytium. This process is distinct from cell aggregation, cell-cell adhesion, and phagocytosis, and it requires dedicated molecular machinery that brings membranes into close apposition, destabilizes them, and drives lipid bilayer merger. Cell-cell fusion is essential for normal development and tissue homeostasis, contributing to fertilization, skeletal muscle formation, bone resorption by osteoclasts, placental development, and immune responses. In addition to these physiological roles, cell-cell fusion is increasingly recognized as a driver of disease, particularly cancer, where fusion between tumor cells or between tumor cells and normal cells can generate hybrids with enhanced metastatic and drug-resistant phenotypes. Viral infections also exploit cell-cell fusion to form syncytia, a hallmark of betaherpesvirus infection and a mechanism of viral spread. Because of its broad relevance, cell-cell fusion is an active area of research spanning developmental biology, immunology, cancer biology, and virology.
cell-cell fusion At A Glance
| GO ID | GO:0140253 |
|---|---|
| GO term | cell-cell fusion |
| Ontology | biological_process |
| Synonym | cell cell fusion; cell fusion; plasma membrane fusion |
| Major function | Merging of plasma membranes of two or more cells into a single cell, with or without nuclear fusion |
| Physiological examples | Fertilization, myoblast fusion, osteoclast formation, placental syncytiotrophoblast formation, macrophage fusion |
| Pathological examples | Cancer cell fusion, viral syncytium formation, chronic inflammatory giant cell formation |
| Key molecular triggers | Phosphatidylserine exposure, fusogenic proteins (e.g., syncytins), actin cytoskeleton remodeling |
| Research relevance | Target for developmental biology, cancer biology, virology, and regenerative medicine studies |
What Is GO:0140253?
According to the Gene Ontology, GO:0140253 cell-cell fusion is defined as a cellular process in which two or more cells combine together, their plasma membrane fusing, producing a single cell. In some cases, nuclei fuse, producing a polyploid cell, while in other cases, nuclei remain separate, producing a syncytium. Synonyms include cell cell fusion, cell fusion, and plasma membrane fusion. This term describes a biological process rather than a molecular function or cellular component, and it encompasses both programmed developmental fusion events and pathological fusion events.
Why Is cell-cell fusion Important in Cell Biology?
Cell-cell fusion is important because it underlies essential physiological processes such as fertilization, skeletal muscle development, bone remodeling, and placental formation, while also contributing to major human diseases including cancer and viral infections. Understanding the molecular mechanisms of cell-cell fusion can reveal new therapeutic targets for cancer metastasis, viral spread, and inflammatory diseases, and can inform regenerative medicine strategies aimed at engineering tissues.
• Essential for fertilization, where sperm and egg membranes fuse to initiate development.
• Required for skeletal muscle formation through myoblast fusion into multinucleated myotubes.
• Critical for bone homeostasis via osteoclast fusion into multinucleated bone-resorbing cells.
• Necessary for placental development, where trophoblast fusion forms the syncytiotrophoblast layer.
• Contributes to immune responses through macrophage fusion into multinucleated giant cells.
• Drives cancer progression by generating hybrid tumor cells with enhanced metastatic potential.
• Mediates viral spread through syncytium formation in betaherpesvirus and other viral infections.
• Involved in tissue repair and regeneration, including fusion of stem cells with differentiated cells.
• Provides a model for studying membrane fusion mechanisms conserved across cell types.
• Offers opportunities for therapeutic intervention in cancer, viral infections, and inflammatory diseases.
What Happens During cell-cell fusion?
Initiation and cell recognition
In simple terms: Cells first recognize each other and get close enough to touch.
Cell-cell fusion begins with specific recognition and adhesion between fusion-competent cells, often mediated by cell-surface proteins and adhesion molecules that bring plasma membranes into close apposition. In developmental fusion, such as myoblast fusion, cells undergo migration and alignment before fusion, while in fertilization, sperm-egg recognition involves species-specific interactions. Phosphatidylserine exposure on the surface of fusion-competent cells acts as a conserved signal that marks cells for fusion and is recognized by receptors on partner cells.
Membrane apposition and hemifusion
In simple terms: The outer layers of the two cell membranes merge first, creating a bridge.
After recognition, the plasma membranes of the fusing cells are brought into close proximity, and the outer lipid leaflets merge in a process called hemifusion. This step is energetically unfavorable and requires fusogenic proteins that insert into the membrane and destabilize lipid bilayers. Actin cytoskeleton remodeling and membrane curvature-generating proteins facilitate the formation of a fusion pore.
Fusion pore formation and expansion
In simple terms: A small opening forms between the cells and then widens until the cells become one.
Following hemifusion, a fusion pore forms and expands, allowing cytoplasmic mixing between the fusing cells. This step is driven by the coordinated action of fusogens, lipids, and cytoskeletal elements that stabilize the expanding pore. In some cases, the fusion pore expands fully, resulting in a single cell with mixed cytoplasm.
Nuclear fusion or syncytium formation
In simple terms: The nuclei may either merge into one or stay separate within a shared cytoplasm.
After cytoplasmic mixing, nuclei may either fuse to form a single polyploid nucleus or remain separate, resulting in a syncytium. Nuclear fusion requires nuclear envelope breakdown and reformation, and is observed in processes such as fertilization and osteoclast formation. In contrast, syncytia are common in placental trophoblast, skeletal muscle, and viral infections, where multiple nuclei share a common cytoplasm.
Post-fusion remodeling and maturation
In simple terms: After fusion, the new cell reorganizes its contents and functions.
Following fusion, the newly formed cell undergoes extensive remodeling of its cytoskeleton, organelles, and gene expression programs to acquire specialized functions. For example, fused myotubes mature into contractile muscle fibers, and fused trophoblasts form a syncytiotrophoblast that supports nutrient exchange. In pathological fusion, such as cancer cell fusion, post-fusion remodeling can lead to increased migratory and invasive capacity.
Key Genes Involved in GO:0140253 cell-cell fusion
The following genes and proteins are key players in cell-cell fusion, as reported in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GCM1 | Trophoblast fusion and placental development | Knockout models show defective syncytiotrophoblast formation |
| ERVFRD-1 | Syncytin-2, fusogenic protein in placenta | Mediates cell-cell fusion in trophoblast |
| ERVW-1 | Syncytin-1, fusogenic protein in placenta | Involved in trophoblast fusion and cancer |
| MYMK | Myoblast fusion in skeletal muscle | Mutations cause Carey-Fineman-Ziter syndrome |
| MYMX | Myoblast fusion and muscle regeneration | Required for myotube formation |
| DCSTAMP | Osteoclast fusion and bone resorption | Knockout mice develop osteopetrosis |
| OCSTAMP | Osteoclast fusion | Regulates multinucleated osteoclast formation |
| ATP6V0D2 | Osteoclast fusion and acidification | Required for bone resorption |
| CD47 | Macrophage fusion and immune regulation | Regulates giant cell formation |
| MMP9 | Macrophage fusion and extracellular matrix remodeling | Involved in giant cell formation |
| EFF-1 | Nematode cell fusion | Model for fusogen function |
| AFF-1 | Nematode cell fusion | Required for organ formation |
| HAP2 | Gamete fusion in fertilization | Conserved fusogen in eukaryotes |
| IZUMO1 | Sperm-egg fusion | Essential for fertilization |
| JUNO | Sperm-egg recognition and fusion | Receptor for IZUMO1 |
| CD9 | Tetraspanin involved in sperm-egg fusion | Required for fertilization |
| TP53 | Regulates cell fusion in cancer | Loss promotes fusion and genomic instability |
| CDK4 | Cell cycle regulation in fusion | Influences fusion competence |
How Is cell-cell fusion Regulated?
Cell-cell fusion is tightly regulated at multiple levels, including transcriptional control of fusogens, post-translational modifications, and signaling pathways. Phosphatidylserine exposure, regulated by phospholipid scramblases and flippases, is a key upstream signal that licenses fusion. In myoblast fusion, transcription factors such as MYOD and MYOG drive expression of fusogenic genes, while actin cytoskeleton regulators control fusion pore formation. In osteoclasts, RANKL signaling induces DCSTAMP and OCSTAMP expression, which are essential for fusion. Viral fusion is regulated by viral glycoproteins and host factors, including proteases that activate fusogens. In cancer, fusion is influenced by genomic instability, hypoxia, and inflammatory signals, and can be promoted by loss of tumor suppressors such as TP53.
cell-cell fusion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYMK | Carey-Fineman-Ziter syndrome | Knockout mouse or patient-derived iPSC myoblasts |
| DCSTAMP | Osteopetrosis | Knockout mouse and osteoclast differentiation assays |
| ERVW-1 | Cancer and placental dysfunction | Overexpression and knockout in cancer cell lines |
| TP53 | Cancer fusion and genomic instability | Knockout in cancer cell lines and fusion assays |
| HAP2 | Infertility | Knockout in model organisms and fertilization assays |
Cancer and metastasis
Cell-cell fusion is increasingly recognized as a mechanism contributing to cancer progression and metastasis. Fusion between tumor cells or between tumor cells and normal cells can generate hybrid cells with combined genetic and phenotypic traits, including enhanced migratory capacity, drug resistance, and metastatic potential. The resulting aneuploidy and genomic instability can accelerate tumor evolution. Fusion-derived hybrids have been detected in various cancers, and fusogens such as syncytins are aberrantly expressed in some tumors.
Viral infections and syncytium formation
Many enveloped viruses, including betaherpesviruses, induce cell-cell fusion to form syncytia, which facilitates viral spread and immune evasion. Syncytium formation is a hallmark of infections by human cytomegalovirus, human herpesvirus 6, and other betaherpesviruses, and is mediated by viral glycoproteins and host factors. Virus-mediated cell-cell fusion can also contribute to tissue damage and pathogenesis.
Developmental and bone disorders
Defects in cell-cell fusion cause developmental and skeletal disorders. Mutations in MYMK cause Carey-Fineman-Ziter syndrome, characterized by muscle weakness and facial anomalies due to defective myoblast fusion. Loss of osteoclast fusion proteins such as DCSTAMP or OCSTAMP leads to osteopetrosis, a disease of increased bone density due to impaired bone resorption. Placental fusion defects can result in pregnancy complications.
Inflammatory and immune disorders
Macrophage fusion into multinucleated giant cells is a feature of chronic inflammatory diseases such as sarcoidosis, tuberculosis, and foreign body reactions. The fusion process is regulated by cytokines and adhesion molecules, and targeting fusion machinery may reduce granuloma formation and associated tissue damage.
From cell-cell fusion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate fusogen required for myoblast fusion? | MYMK or MYMX knockout in C2C12 cells or mouse models |
| Does a point mutation in DCSTAMP affect osteoclast fusion? | Point-mutation knock-in in osteoclast precursor cells |
| Can a tagged fusogen be tracked during fusion? | Knock-in of fluorescent tag at endogenous locus |
| Does overexpression of syncytin drive cancer cell fusion? | Overexpression of ERVW-1 in cancer cell lines |
| Which genes regulate trophoblast fusion? | CRISPR knockout screen in trophoblast stem cells |
| Does a viral glycoprotein induce syncytia? | Overexpression of viral fusogen in permissive cells |
How to Study the cell-cell fusion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Time-lapse fluorescence microscopy | Membrane and nuclear fusion dynamics | Visualizing myoblast or trophoblast fusion |
| Annexin V staining | Phosphatidylserine exposure | Detecting fusion-competent cells |
| CRISPR knockout screen | Genes required for fusion | Identifying novel fusogens |
| RNA-seq | Transcriptional changes during fusion | Characterizing fusion-competent states |
| Proteomics | Protein expression and interactions | Discovering fusogen complexes |
| Flow cytometry | Fusion efficiency and hybrid cell detection | Quantifying cancer cell fusion |
| Syncytia assay | Viral or cellular syncytium formation | Testing viral fusogens or cancer fusogens |
Imaging-based fusion assays
Cell-cell fusion can be visualized using fluorescent labeling of plasma membranes and nuclei, followed by time-lapse microscopy to track membrane merger and nuclear fusion. Dual-color labeling allows discrimination between hemifusion, pore formation, and syncytium formation. High-content imaging enables quantification of fusion efficiency in large-scale screens.
Genetic screens and CRISPR libraries
CRISPR knockout and activation screens have been used to identify genes required for cell-cell fusion in various cell types, including myoblasts and trophoblasts. Pooled screens with next-generation sequencing readouts can uncover novel fusogens and regulatory pathways. These approaches are complemented by RNA-seq and proteomics to validate hits.
Biochemical and proteomic approaches
Proteomic analysis of fusion-competent cells can identify changes in surface proteins and signaling pathways. Phosphatidylserine exposure can be measured by annexin V binding, and lipid composition can be analyzed by mass spectrometry. Co-immunoprecipitation and proximity labeling can reveal fusogen interactors.
Functional validation with CRISPR models
Candidate genes identified in screens can be validated by CRISPR knockout, point mutation, or overexpression in relevant cell models. For example, knockout of DCSTAMP abolishes osteoclast fusion, while overexpression of syncytins induces fusion in non-fusogenic cells. These models provide causal evidence for gene function in cell-cell fusion.
How CRISPR Can Be Used to Study GO:0140253 cell-cell fusion
Knockout
CRISPR knockout is used to delete candidate fusogen genes to test their requirement for cell-cell fusion. For example, knockout of MYMK or DCSTAMP abolishes myoblast or osteoclast fusion, respectively. Knockout models are essential for establishing causality in fusion pathways.
Point Mutation
Point mutations can be introduced to model disease-associated variants or to dissect functional domains of fusogens. For instance, point mutations in DCSTAMP identified in osteopetrosis patients can be knocked into cell lines to assess effects on fusion. This approach provides insights into structure-function relationships.
Knock-in
Knock-in of fluorescent tags or reporter genes at endogenous loci allows real-time tracking of fusogen expression and localization during fusion. Tagged knock-in models are valuable for imaging fusion events and for isolating fusion-competent cells.
Overexpression
Overexpression of candidate fusogens, such as syncytins, can induce cell-cell fusion in otherwise non-fusogenic cells, providing gain-of-function evidence. Overexpression models are also used to study viral fusogens and cancer cell fusion.
How EDITGENE Supports cell-cell fusion Research
Researchers studying cell-cell fusion-related genes often need to determine whether a candidate gene is causally involved in fusion, and CRISPR-based models provide the most direct way to test this. EDITGENE offers a comprehensive suite of services to support such studies.
Contact EDITGENE today to design your custom CRISPR model for cell-cell fusion research.
Frequently Asked Questions About cell-cell fusion
What is cell-cell fusion (GO:0140253)?
Cell-cell fusion is a biological process in which two or more cells combine by plasma membrane fusion to form a single cell, with or without nuclear fusion.
What genes are involved in cell-cell fusion?
Key genes include MYMK, MYMX, DCSTAMP, OCSTAMP, ERVW-1, ERVFRD-1, HAP2, IZUMO1, and CD9, among others.
Why is cell-cell fusion important in cancer?
Cell-cell fusion can generate hybrid tumor cells with enhanced metastatic potential and drug resistance, contributing to cancer progression.
How do viruses use cell-cell fusion?
Viruses such as betaherpesviruses induce cell-cell fusion to form syncytia, facilitating viral spread and immune evasion.
What is the difference between cell-cell fusion and syncytium formation?
Cell-cell fusion is the process; syncytium formation is one outcome where nuclei remain separate within a shared cytoplasm.
What are the main steps of cell-cell fusion?
The main steps are initiation and recognition, membrane apposition and hemifusion, fusion pore formation, nuclear fusion or syncytium formation, and post-fusion remodeling.
What role does phosphatidylserine play in cell-cell fusion?
Phosphatidylserine exposure on the cell surface acts as a conserved signal that marks cells for fusion and is recognized by partner cells.
Can CRISPR be used to study cell-cell fusion?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in cell-cell fusion.
What diseases are associated with defective cell-cell fusion?
Defective fusion is linked to Carey-Fineman-Ziter syndrome, osteopetrosis, infertility, and placental disorders.
How is cell-cell fusion measured in the lab?
Common methods include time-lapse fluorescence microscopy, annexin V staining, flow cytometry, and syncytia assays.
Conclusion
Cell-cell fusion (GO:0140253) is a fundamental biological process with essential roles in development, homeostasis, and disease. Its molecular mechanisms involve conserved fusogens, lipid signaling, and cytoskeletal remodeling, and its dysregulation contributes to cancer, viral infections, and developmental disorders. Continued research using CRISPR-based models and advanced imaging will further illuminate how cells fuse and how this process can be targeted therapeutically.
References
- 1. Leroy H et al.. 2020. Virus-Mediated Cell-Cell Fusion.. Int J Mol Sci 21(24) PMID: 33348900
- 2. Chen EH et al.. 2007. Cell-cell fusion.. FEBS Lett 581(11):2181-93 PMID: 17395182
- 3. Shultes PV et al.. 2024. Cell-cell fusion in cancer: The next cancer hallmark?. Int J Biochem Cell Biol 175:106649 PMID: 39186970
- 4. Sieler M et al.. 2024. Cell Fusion and Syncytia Formation in Cancer.. Results Probl Cell Differ 71:433-465 PMID: 37996689
- 5. Tang J et al.. 2021. Cell Fusion and Syncytium Formation in Betaherpesvirus Infection.. Viruses 13(10) PMID: 34696402
- 6. Iosilevskii Y et al.. 2021. Programmed cell fusion in development and homeostasis.. Curr Top Dev Biol 144:215-244 PMID: 33992154
- 7. Peng XC et al.. 2021. Cell‑cell fusion as an important mechanism of tumor metastasis (Review).. Oncol Rep 46(1) PMID: 34080662
- 8. Whitlock JM et al.. 2021. Flagging fusion: Phosphatidylserine signaling in cell-cell fusion.. J Biol Chem 296:100411 PMID: 33581114
